Page last updated: 2024-10-29

iohexol and Endocrine Gland Neoplasms

iohexol has been researched along with Endocrine Gland Neoplasms in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Endocrine Gland Neoplasms: Tumors or cancer of the ENDOCRINE GLANDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lefort, T1
Pilleul, F1
Mulé, S1
Bridal, SL1
Frouin, F1
Lombard-Bohas, C1
Walter, T1
Lucidarme, O1
Guibal, A1

Other Studies

1 other study available for iohexol and Endocrine Gland Neoplasms

ArticleYear
Correlation and agreement between contrast-enhanced ultrasonography and perfusion computed tomography for assessment of liver metastases from endocrine tumors: normalization enhances correlation.
    Ultrasound in medicine & biology, 2012, Volume: 38, Issue:6

    Topics: Adult; Aged; Blood Volume; Contrast Media; Endocrine Gland Neoplasms; Female; Humans; Iohexol; Liver

2012